ArgBP2, encoding a negative regulator of ABL, is fused to MLL in a case of infant M5 acute myeloid leukemia involving 4q35 and 11q23
Open Access
- 20 April 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (7) , 1310-1313
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocolsLeukemia, 2005
- ArgBP2γ Interacts with Akt and p21-activated Kinase-1 and Promotes Cell SurvivalJournal of Biological Chemistry, 2005
- The Abl/Arg substrate ArgBP2/nArgBP2 coordinates the function of multiple regulatory mechanisms converging on the actin cytoskeletonProceedings of the National Academy of Sciences, 2005
- New insight into the molecular mechanisms of MLL-associated leukemiaLeukemia, 2004
- Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-AblBiochemical Journal, 2003
- The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21)Oncogene, 2003
- Panhandle PCR for cDNA: A rapid method for isolation of MLL fusion transcripts involving unknown partner genesProceedings of the National Academy of Sciences, 2000
- Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpointsLeukemia, 1998